These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23474960)

  • 1. Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging.
    Kajihara M; Goto M; Hirayama Y; Okunishi S; Kaoku S; Konishi E; Shinkura N
    Magn Reson Med Sci; 2013 Mar; 12(1):39-45. PubMed ID: 23474960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.
    Amarosa AR; McKellop J; Klautau Leite AP; Moccaldi M; Clendenen TV; Babb JS; Zeleniuch-Jacquotte A; Moy L; Kim S
    Radiology; 2013 Aug; 268(2):356-65. PubMed ID: 23657893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population.
    Kamitani T; Yabuuchi H; Kanemaki Y; Tozaki M; Sonomura T; Mizukoshi W; Nakata W; Shimono T; Urano M; Yamano T; Kato F; Kuchiki M; Shiragami N; Yanagita H; Katsuda E; Kataoka M; Yamaguchi K; Horikoshi T; Gomi T; Nozaki M; Shiotani M; Amano M; Saigusa H; Sadaoka S; Kamiya H; Kubo M; Yamashita N; Yamamoto H; Honda H
    Eur J Radiol; 2019 Jan; 110():130-135. PubMed ID: 30599849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
    Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
    Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MR-imaging of the breast at 0.5 Tesla: menstrual-cycle dependency of parenchymal contrast enhancement in healthy volunteers with oral contraceptive use?].
    Lorenzen J; Welger J; Lisboa BW; Krupski G; Adam G
    Rofo; 2003 Apr; 175(4):502-6. PubMed ID: 12677505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition.
    Kang SS; Ko EY; Han BK; Shin JH; Hahn SY; Ko ES
    J Magn Reson Imaging; 2014 Mar; 39(3):526-34. PubMed ID: 23633296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue.
    Delille JP; Slanetz PJ; Yeh ED; Kopans DB; Garrido L
    Breast J; 2005; 11(4):236-41. PubMed ID: 15982388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing.
    Zhao S; Zhang X; Zhong H; Qin Y; Li Y; Song B; Huang J; Yu J
    Sci Rep; 2020 May; 10(1):8608. PubMed ID: 32451404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Association Between Menstrual Cycle Timing and Quantitative Background Parenchymal Enhancement on Breast MRI in Premenopausal Women.
    He Y; Zhou J; Liu X; Wei Y; Ye S; Miao H; Liu H; Chen Z; Zhao Y; Wang M
    Clin Breast Cancer; 2023 Oct; 23(7):e451-e457.e1. PubMed ID: 37640598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
    Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
    Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
    Giess CS; Yeh ED; Raza S; Birdwell RL
    Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density.
    Scaranelo AM; Carrillo MC; Fleming R; Jacks LM; Kulkarni SR; Crystal P
    Radiology; 2013 Jun; 267(3):692-700. PubMed ID: 23418005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast.
    Müller-Schimpfle M; Ohmenhaüser K; Stoll P; Dietz K; Claussen CD
    Radiology; 1997 Apr; 203(1):145-9. PubMed ID: 9122383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Menstrual Cycle Timing on Screening Breast MRI Background Parenchymal Enhancement and Diagnostic Performance in Premenopausal Women.
    Dontchos BN; Rahbar H; Partridge SC; Lehman CD; DeMartini WB
    J Breast Imaging; 2019 Sep; 1(3):205-211. PubMed ID: 31538142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
    AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
    King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
    Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of Screening MRI in Premenopausal Women as a Function of the Week of the Menstrual Cycle.
    Lee CH; Bryce Y; Zheng J; Sung JS; Comstock CE; Moskowitz C; A Morris E
    AJR Am J Roentgenol; 2020 May; 214(5):1175-1181. PubMed ID: 32160053
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Magn Reson Imaging; 2016 Feb; 34(2):173-6. PubMed ID: 26597834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
    Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
    AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.